BioPredictive

Biopsy is a medical procedure which consists of taking a liver sample using an adapted needle for analyzing it under the microscope.

FibroTest is a diagnostic tool based on a simple blood test.

Biopsy is an imperfect diagnostic tool and has a mean error of 30%.
It is not without risk or pain: 1 patient out of 3 complains of pain, 6 out of 1,000 have severe complications and regrettably, death occurs for 3 patients per 10,000 biopsies, which is unacceptable for a diagnosis.

FibroTest is a simple blood test which has the same relevance as a 25 mm biopsy.

The benefit/risk ratio of biopsy is not suitable for the diagnoses of the most common liver diseases. Biopsy remains useful as a second-line tool in cases where the FibroTest are not applicable or in rare liver diseases or complexes.

In conclusion, FibroTest has the same diagnostic value as a 25 mm biopsy, using a simple blood test, without pain and without risk, and can be easily repeated by the physician if necessary.